Tempest Therapeutics, Inc. Common Stock (TPST) is a publicly traded Healthcare sector company. As of October 24, 2026, TPST trades at $0.52 with a market cap of $8.82M and a P/E ratio of -0.12. TPST moved -2.35% today. Year to date, TPST is -81.88%; over the trailing twelve months it is -95.05%. Its 52-week range spans $0.50 to $12.23. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces TPST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TPST, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $8.82M |
| P/E Ratio | -0.12 |
| EPS | $-6.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $0.50 |
| Volume | 52.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.26M |
| Gross Margin | 0.00% |
1 analysts cover TPST: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.